Izvorni znanstveni članak

DEPRESSION DISORDERS IN PATIENTS WITH CHRONIC HEPATITIS C

Helien Bebek-Ivankovic ; Department of Infectology, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina
Milenko Bevanda ; Department of Internal Diseases, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina
Bozo Susak ; Department of Infectology, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina
Svjetlana Grgic ; Department of Infectology, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina
Linda Soldo-Coric ; Department of Infectology, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina
Jadranka Nikolic ; Department of Infectology, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina

Sažetak

Background: Chronic hepatitis C was until recently treated with a combined therapy of interferon and ribavirin. More recently,
direct antiviral agents (DAA), are being introduced. They are more tolerable and have fewer side effects, with better treatment
results. In the Federation of Bosnia and Herzegovina we have started using this new therapy, with a limited financial opportunity. Large numbers of patients with chronic hepatitis C are former or current addicts, some of them treat their addiction with methadone or buprenorphine. These patients often formerly have a depression disorder and during treatment of chronic hepatitis need supervision of a psychiatrist, due to one of the side effects of interferon being deterioration of depression. Using this research we wanted to valorize the depression disorder of our patients, to indicate the effects of interferon on depression deterioration and the need for a new therapy protocol.
Subjects and methods: Examinees were patients with chronic hepatitis C on interferon therapy, which we divided into three groups: those who were never addicts, then the group of patients who were earlier addicts and have a long abstinence and patients who treat their addiction with a replacement therapy of methadone or buprenorphine. All patients completed Beck’s test, which determines the level of depression, before and after interferon therapy.
Results: Patients who used to be addicts or were on replacement therapy had mild or moderate depression before interferon
treatment in a large number. After interferon therapy, there was a statistically substantial increase of patients with serious depression, which was not noted before the therapy.
Conclusion: Interferon therapy deteriorates depression in patients with chronic hepatitis C and there should be a strive for new
therapies with less side effects in treatment. No patients stopped therapy. That is a result of community work and supervision over patients from both hepatologists and psychiatrists.

Ključne riječi

hepatitis C; depression; interferon; addicts

Hrčak ID:

262641

URI

https://hrcak.srce.hr/262641

Datum izdavanja:

18.11.2020.

Posjeta: 309 *